<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02907814</url>
  </required_header>
  <id_info>
    <org_study_id>Pro20160000585</org_study_id>
    <nct_id>NCT02907814</nct_id>
  </id_info>
  <brief_title>Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography</brief_title>
  <official_title>Objective, Prospective Measurement of Anterior Chamber Cell Grading Using Anterior Chamber Ocular Coherence Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rutgers, The State University of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rutgers, The State University of New Jersey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Optical Coherence Tomography (OCT) is routinely used in ophthalmic clinical practice. It uses
      infrared light to image patient's eyes. Some patients, such as those with an inflammatory
      disease called uveitis or those who have just undergone cataract surgery, have intraocular
      inflammation. This intraocular inflammation commonly manifests as cells that can be seen on
      routine microscopic clinical examination. However, the only currently available method to
      quantify this intraocular inflammation is by manually counting on the microscopic clinical
      examination. The investigators plan to use the OCT machine to image patient's eyes. The
      investigators will then use the images obtained from the OCT to objectively quantify the
      degree of intraocular inflammation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Identification of inflammatory cells on OCT scan</measure>
    <time_frame>Through study completion, up to 1 year.</time_frame>
    <description>Identification of cells in OCT scan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in cell density identified by OCT scans over time</measure>
    <time_frame>Baseline and up to 8 weeks.</time_frame>
    <description>Identification of changes in cell density in OCT scans over time</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Uveitis</condition>
  <arm_group>
    <arm_group_label>Uveitis and Cataract Imaging Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will undergo up to three optical coherence tomography scans.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Control subjects will undergo a brief, non-contact eye exam and then undergo up to three optical coherence tomography scans.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optical Coherence Tomography (OCT)</intervention_name>
    <description>The OCT scan is a brief, non-contact scan of the back of the eye using infrared light. Subjects will see a light and be asked to look forwards while the scan is completed.</description>
    <arm_group_label>Uveitis and Cataract Imaging Group</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Eye Exam</intervention_name>
    <description>This is a brief, non-contact ocular exam.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18 years old

          -  Intervention Arm:

               -  Active anterior chamber inflammation in at least one eye as diagnosed by clinical
                  exam

               -  One of the following: 1) diagnosis of uveitis OR 2) undergone cataract extraction
                  surgery within the previous 30 days

          -  Control Arm:

               -  No active intraocular inflammation based on clinical exam

        Exclusion Criteria:

          -  Corneal opacities in the affected eye

          -  Anyone judged unable to understand or consent to study participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David S Chu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rutgers New Jersey Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David S Chu, MD</last_name>
    <phone>973-972-2064</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elliot S Crane, BA</last_name>
    <phone>973-972-2037</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Doctors Office Center</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elliot Crane, BA</last_name>
      <phone>973-972-2037</phone>
      <email>cranees@njms.rutgers.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.lia.org/subscriptions/safety_bulletin/laser_safety_information</url>
    <description>Laser Safety Information. Laser Institute of America 2016.</description>
  </link>
  <reference>
    <citation>Kempen JH, Ganesh SK, Sangwan VS, Rathinam SR. Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis. Am J Ophthalmol. 2008 Dec;146(6):813-8.e1. doi: 10.1016/j.ajo.2008.06.004. Epub 2008 Aug 8.</citation>
    <PMID>18687418</PMID>
  </reference>
  <reference>
    <citation>Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005 Sep;140(3):509-16. Review.</citation>
    <PMID>16196117</PMID>
  </reference>
  <reference>
    <citation>User Manual: SPECTRALIS HRA+OCT. Heidelberg Engineering GmbH;2012.</citation>
  </reference>
  <reference>
    <citation>Agarwal A, Ashokkumar D, Jacob S, Agarwal A, Saravanan Y. High-speed optical coherence tomography for imaging anterior chamber inflammatory reaction in uveitis: clinical correlation and grading. Am J Ophthalmol. 2009 Mar;147(3):413-416.e3. doi: 10.1016/j.ajo.2008.09.024. Epub 2008 Dec 3.</citation>
    <PMID>19054493</PMID>
  </reference>
  <reference>
    <citation>Li Y, Lowder C, Zhang X, Huang D. Anterior chamber cell grading by optical coherence tomography. Invest Ophthalmol Vis Sci. 2013 Jan 9;54(1):258-65. doi: 10.1167/iovs.12-10477.</citation>
    <PMID>23249705</PMID>
  </reference>
  <reference>
    <citation>Igbre AO, Rico MC, Garg SJ. High-speed optical coherence tomography as a reliable adjuvant tool to grade ocular anterior chamber inflammation. Retina. 2014 Mar;34(3):504-8. doi: 10.1097/IAE.0b013e31829f73bd.</citation>
    <PMID>23945636</PMID>
  </reference>
  <reference>
    <citation>Sharma S, Lowder CY, Vasanji A, Baynes K, Kaiser PK, Srivastava SK. Automated Analysis of Anterior Chamber Inflammation by Spectral-Domain Optical Coherence Tomography. Ophthalmology. 2015 Jul;122(7):1464-70. doi: 10.1016/j.ophtha.2015.02.032. Epub 2015 Apr 4.</citation>
    <PMID>25846846</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2016</study_first_submitted>
  <study_first_submitted_qc>September 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2016</study_first_posted>
  <last_update_submitted>March 20, 2017</last_update_submitted>
  <last_update_submitted_qc>March 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Uveitis</keyword>
  <keyword>Optical Coherence Tomography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uveitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

